PE04.02 Tenofovir-only and tenofovir/levonorgestrel intravaginal rings are unlikely to impact the genital microbiota of sub-Saharan womenE-posterClinical trial results
OA12.03 Tetravalent immunogen assembled from conserved regions of HIV-1 and delivered as mRNA demonstrates potent preclinical T cell immunogenicity and breadthOral Abstract SessionNovel vaccine and other prevention approaches
PE28.10LB The FCGR2C allele that associates with protection against HIV-1 acquisition in the Thai RV144 HIV-1 vaccine trial is associated with increased risk of perinatal HIV-1 acquisition in South African childrenE-posterTransmission of HIV
PE28.08 The association of a4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with menE-posterTransmission of HIV
PE11.15 The changing transmission dynamics of HIV-1 CRF01_AE in Japan: increased presence of men who have sex with men (MSM)E-posterEpidemiology of HIV
OA13.04 The COVID-19 pandemic and transition to telehealth: appointment attendance and patient perspectives at an adult HIV clinicOral Abstract SessionBehavioural and social science research
PE20.02 The effect of HPV-associated anal dysplasia on HIV susceptibility in men who have sex with menE-posterMicrobiome & STI: impact on prevention
OA11.01 The evolution of oral PrEP access: tracking trends in global oral PrEP use over timeOral Abstract SessionImplementation science, including structural interventions, PrEP & VMMC
PE20.08 The impact of human immunodeficiency virus-1 viral replicative capacity on infection of human cervical and rectal tissue explants ex vivoE-posterMucosal immunity
OA22.05 The impact of penile-vaginal sex on penile immune correlates of HIV susceptibilityOral Abstract SessionMucosal immunity
seek-warrow-warrow-eseek-e381 - 390 of 444 items